|
|
 |
|
Viewing report
|
|
|
|
AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testing in Pharmacogenetics
GlobalData, April 2011, Pages: 4
AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testing in Pharmacogenetics - Deal Analysis from GlobalData
Summary
GlobalData’s medical equipment report, “AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testing in Pharmacogenetics” provides key insights on the deal. The report provides analysis and impact on the global in-vitro diagnostics market as a result of the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Deal overview of the partnership between AutoGenomics and PGXL Laboratories.
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry and on both the companies.
- Company profiles of AutoGenomics and PGXL Laboratories.
Reasons to buy
- Understand the business strategy behind the deal involving the pioneer of pharmacogenetic testing.
- Explore possible repercussions on the market dynamics of in-vitro medical equipment industry.
|
|
|
|
